IBO
Impact BioMedical, Inc.
18 hedge funds and large institutions have $305K invested in Impact BioMedical, Inc. in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$164K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$19.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
$32.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$25.7K |
| 5 |
Two Sigma Investments
New York
|
$14.7K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$21K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
HF
HRT Financial
New York
|
$6K |
| 4 |
Morgan Stanley
New York
|
$0 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
$938 |
